BU-NOT-SET

CONTACT US
Dispensing traceability over the counter
  • Manufacturing
Eyes
Insight
The Final Countdown: CDMO focus areas before February 2019
  • Manufacturing
Eyes
Insight
Changing dynamics: the CDMO market in focus
  • Industry trends
Eyes
Insight
Formulation development trends
  • Drug product
Eyes
Insight
One-year countdown to Brexit
  • Industry trends
Eyes
Insight
High throughput screening platform for liquid formulation design
  • Drug product
Man lab
White paper
Could limited access to the EU Hub threaten serialization readiness?
  • Manufacturing
Eyes
Insight
On the pathway to clinic, solubility remains one of the biggest hurdles: CDMO
  • Drug product
Eyes
Insight
US DSCSA: data standardisation
  • Manufacturing
Eyes
Insight
Insight
  • Biologics
Enhancing the production of RNA with continuous manufacturing
Fact sheet
  • Drug product
GERTEIS MINI-PACTOR® Advanced dry granulation services
Case study
  • Biologics
Overcoming oncolytic virus therapy production challenges through collaboration
Insight
  • Industry trends
Emerging trends set to impact drug development in 2024
Webinar
  • Biologics
Webinar: ATMPs in focus: Essential CMC strategies for every phase
Insight
  • Drug product
  • Industry trends
Trends set to make an impact on oral solid dose development in 2024
Insight
  • Biologics
Enhancing AAV therapy development and manufacture with a platform approach
Insight
  • Drug product
  • Industry trends
Challenges and solutions to enhancing mRNA stability with lyophilisation processes
Insight
  • Industry trends
  • Manufacturing
A well-equipped CDMO for OSD contract manufacturing